or Try an Advanced Search...

    Her2/Neu Stocks List

    Symbol Grade Name % Change
    MACK B Merrimack Pharmaceuticals, Inc. -0.20
    GTHX B G1 Therapeutics, Inc. 1.13
    GLSI D Greenwich LifeSciences, Inc. 2.86
    PBYI D Puma Biotechnology Inc -2.02
    OLMA F Olema Pharmaceuticals, Inc. 5.96
    ZNTL F Zentalis Pharmaceuticals, Inc. 5.40
    BOLT F Bolt Biotherapeutics, Inc. 0.00
    MRKR F Marker Therapeutics, Inc. 0.48
    View As Page of Charts
    Related Industries: Biotechnology
    Related Stock Lists: Breast Cancer Her2 Treatment Of Breast Cancer Biopharmaceutical Cancer Medicine Epidermal Growth Factor Receptor Antiestrogens Clinical Medicine Estrogen Estrogen Receptor Hormones Selective Estrogen Receptor Degraders Treatment Of Cancer Tyrosine Kinase Receptors Cancer Immunotherapy Cancer Treatment Drugs Fulvestrant Immunotherapy

    Related ETFs - A few ETFs which own one or more of the above listed Her2/Neu stocks.

    Symbol Grade Name Weight
    BBC D Virtus LifeSci Biotech Clinical Trials ETF 1.31
    LABD D Direxion Daily S&P Biotech Bear 3X Shares 1.07
    CNCR D Loncar Cancer Immunotherapy ETF 1.05
    SBIO D ALPS Medical Breakthroughs ETF 0.87
    XBI D SPDR S&P Biotech ETF 0.77
    View all Her2/Neu ETFs...
    Compare ETFs
    Compare BBC to XBI Compare LABD to SBIO Compare SBIO to XBI

        Her2/Neu Stocks Recent News

        Date Stock Title
        May 3 PBYI Puma Biotechnology, Inc. (NASDAQ:PBYI) Q1 2024 Earnings Call Transcript
        May 3 PBYI Puma Biotechnology's (PBYI) Q1 Earnings and Revenues Beat
        May 3 GTHX G1 Therapeutics First Quarter 2024 Earnings: Revenues Disappoint
        May 3 PBYI Puma Biotechnology Inc (PBYI) Q1 2024 Earnings Call Transcript Highlights: A Detailed Review of ...
        May 3 PBYI Puma Biotechnology, Inc. (PBYI) Q1 2024 Earnings Call Transcript
        May 2 PBYI Puma Biotechnology, Inc. 2024 Q1 - Results - Earnings Call Presentation
        May 2 PBYI Puma Biotechnology Inc (PBYI) Reports Q1 Financial Results, Misses Analyst Revenue and EPS Forecasts
        May 2 PBYI Puma Biotechnology Non-GAAP EPS of -$0.05 beats by $0.10, revenue of $43.8M misses by $5.25M
        May 2 PBYI Puma Biotechnology Reports First Quarter Financial Results
        May 2 GTHX G1 Therapeutics, Inc. (NASDAQ:GTHX) Q1 2024 Earnings Call Transcript
        May 2 GTHX G1 Therapeutics Inc (GTHX) Q1 2024 Earnings Call Transcript Highlights: Strong Revenue Growth ...
        May 2 GTHX Q1 2024 G1 Therapeutics Inc Earnings Call
        May 1 PBYI Puma Biotechnology Q1 2024 Earnings Preview
        May 1 GTHX G1 Therapeutics, Inc. (GTHX) Q1 2024 Earnings Call Transcript
        May 1 GTHX G1 Therapeutics and Pepper Bio sign license agreement for lerociclib
        May 1 GTHX G1 Therapeutics Inc (GTHX) Q1 2024 Earnings: Close Alignment with Analyst Revenue Projections
        May 1 GTHX G1 Therapeutics (GTHX) Reports Q1 Loss, Lags Revenue Estimates
        May 1 OLMA Olema Oncology to Participate in Upcoming Investor Conferences in May
        May 1 GTHX G1 Therapeutics reports mixed Q1 results; reaffirms FY24 outlook
        May 1 GTHX G1 Therapeutics Provides First Quarter 2024 Financial Results and Operational Highlights
        Related Industries: Biotechnology
        Related Stock Lists: Breast Cancer Her2 Treatment Of Breast Cancer Biopharmaceutical Cancer Medicine Epidermal Growth Factor Receptor Antiestrogens Clinical Medicine Estrogen Estrogen Receptor Hormones Selective Estrogen Receptor Degraders Treatment Of Cancer Tyrosine Kinase Receptors Cancer Immunotherapy Cancer Treatment Drugs Fulvestrant Immunotherapy
        Her2/Neu

        Browse All Tags